2,3-Diarylbenzopyran derivatives as a novel class of selective cyclooxygenase-2 inhibitors

被引：70

作者：

Joo, YH ^{[1
]}

Kim, JK ^{[1
]}

Kang, SH ^{[1
]}

Noh, MS ^{[1
]}

Ha, JY ^{[1
]}

Choi, JK ^{[1
]}

Lim, KM ^{[1
]}

Lee, CH ^{[1
]}

Chung, S ^{[1
]}

机构：

[1] AmorePacific Corp, R&D Ctr, Drug Discovery, Yongin 449729, Kyounggi Do, South Korea

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2003年 / 13卷 / 03期

关键词：

D O I：

10.1016/S0960-894X(02)00952-6

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A new series of cyclooxygenase-2(COX-2) inhibitors with naturally occurring flavone as the main skeleton has been synthesized and their biological activities were evaluated for cyclooxygenase inhibitory activity. Rational structural modifications were applied to potent COX-2 inhibitors to obtain the desired pharmacokinetic profiles for improved oral anti-inflammatory activity. (C) 2002 Elsevier Science Ltd. All rights reserved.

引用

页码：413 / 417

页数：5

共 50 条

[31] Renal effects of cyclooxygenase-2 selective inhibitors
Harris, CJ
Brater, DC
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (05): : 603 - 610
[32] Derivatives of benzosulfonamides as inhibitors of the enzyme cyclooxygenase-2
不详
EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (08) : 899 - 901
[33] Nephrotoxic potential of selective cyclooxygenase-2 inhibitors
Sandhu, GK
Heyneman, CA
ANNALS OF PHARMACOTHERAPY, 2004, 38 (04) : 700 - 704
[34] Selective cyclooxygenase-2 inhibitors: hope and facts
Berenbaum, F
JOINT BONE SPINE, 2000, 67 (06) : 499 - 501
[35] Selective cyclooxygenase-2 inhibitors: similarities and differences
Brune, K
Hinz, B
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2004, 33 (01) : 1 - 6
[36] Selective cyclooxygenase-2 inhibitors for the treatment of arthritis
Fung, HB
Kirschenbaum, HL
CLINICAL THERAPEUTICS, 1999, 21 (07) : 1131 - 1157
[37] Cardiovascular risk of selective cyclooxygenase-2 inhibitors
Schrör, K
Mehta, P
Mehta, JL
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2005, 10 (02) : 95 - 101
[38] Pyridazinones as selective cyclooxygenase-2 inhibitors.
Li, CS
Brideau, C
Chan, CC
Savoie, C
Claveau, D
Charleson, S
Gordon, R
Greig, G
Gauthier, JY
Lau, CK
Riendeau, D
Therien, M
Wong, E
Prasit, P
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U210 - U210
[39] Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models
Palomer, A
Cabré, F
Pascual, J
Campos, J
Trujillo, MA
Entrena, A
Gallo, MA
García, L
Mauleón, D
Espinosa, A
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (07) : 1402 - 1411
[40] The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part III: The three microdose candidates
Wang, Jane L.
Aston, Karl
Limburg, David
Ludwig, Cindy
Hallinan, Ann E.
Koszyk, Francis
Hamper, Bruce
Brown, David
Graneto, Matthew
Talley, John
Maziasz, Timothy
Masferrer, Jaime
Carter, Jeffery
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (23) : 7164 - 7168

← 1 2 3 4 5 →